OBJECTIVES
To characterize clinical manifestations, major organ involvement, real-world treatment patterns, and factors associated with severity classification in Japanese patients with mixed connective tissue disease (MCTD), aiming to clarify its heterogeneous clinical spectrum.
METHODS
This nationwide retrospective...
S. Kubo, Yurie Kanda, Hideto Kameda et al.· Rheumatology· 0 citations
OBJECTIVES
To evaluate the effectiveness and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA)-associated progressive pulmonary fibrosis (PPF).
METHODS
Real-world data were retrospectively collected in RA-associated PPF during the first year after bDMARD initiation. The...
R. Kanda, Yoshiya Tanaka, Y. Miyazaki et al.· Rheumatology· 0 citations
This review summarizes advances in SLE stratification based on immune phenotyping and multi-omics approaches and outlines emerging therapies, including biologics, intracellular inhibitors, and cell-based treatments.
Yurie Satoh-Kanda, S. Nakayamada, Yoshiya Tanaka· Expert Review of Clinical Im...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.